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Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publisher and the editor(s). The appearance of advertisements in the journal is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. This special issue of Neuroendocrinology provides the updated and revised version of the previously published and most cited ENETS guidelines. It is the fi nal product of a three-day consensus meeting held in Barcelona where old and recent data on new evidence and insights, were intensely discussed in working group and plenary sessions. Each paper covers the topics of epidemiology, prognosis, clinical presentation, imaging, laboratory tests, pathology and genetics, therapeutic strategies and follow-up recommendations for each neuroendocrine tumor of the gastrointestinal tract and pancreas. Notes were taken continuously so that the fi nal agreement on each question was noted and returned to each session chair for preparation of the consensus statements and papers. The consensus sessions covered the following neuroendocrine neoplasm-related topics by sites of origin or stage: gastroduodenal, hindgut, functional pancreatic, nonfunctional pancreatic, midgut (including appendix), and a fi nal session that covered liver and other distant metastases from neuroendocrine neoplasms of any origin. 
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